FindTrial
Sign In

Multi-collaboration contributes to HCV DBU relink in Guangdong China

Multi-collaboration contributes to HCV DBU relink in Guangdong China

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400083274
Enrollment
Unknown
Registered
2024-04-19
Start date
2024-04-22
Completion date
Unknown
Last updated
2024-04-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hepatitis C

Interventions

Relink group:Well-trained HCV Relink Team and follow the usual treatment strategy for hepatitis C.

Sponsors

Guangzhou Eighth People's Hospital, Guangzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: ?Patients aged 18 years old and above ?Patients with HCV RNA positive from 2022 to 2023

Exclusion criteria

Exclusion criteria: Patients who have blank numbers/wrong numbers

Design outcomes

Primary

MeasureTime frame
HCV DBU relink rate;—

Secondary

MeasureTime frame
diagnosis rate;treatment rate;SVR12 visit rate;modified relink rate;—

Countries

China

Contacts

Public ContactYujuan Guan

Guangzhou Eighth People's Hospital, Guangzhou Medical University

gz8hgyj@126.com+86 136 3229 3277

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026